dual gip and glp-1 receptor agonist GIP/GLP-1 agonists: New advances for treating type-2 diabetes Frontiers | GLP-1/GIP dual agonist

Whats next for multi-receptor agonists The recent success and clinical implementation of tirzepatide has accelerated interest in the pursuit of MRA

G protein-coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus

How may GIP enhance the therapeutic efficacy of GLP-1

Association of GLP-1 receptor agonists with risk of suicidal ideation and behaviour: a systematic review and meta-analysis

Zelniker, T

Experiments in primary islets reveal -arrestin1 limits the insulin response to GLP-1, but not GIP or tirzepatide, suggesting that the biased agonism of tirzepatide enhances insulin secretion